SAVINELLI, STEFANO
 Distribuzione geografica
Continente #
NA - Nord America 878
EU - Europa 236
AS - Asia 184
AF - Africa 2
OC - Oceania 2
Continente sconosciuto - Info sul continente non disponibili 1
SA - Sud America 1
Totale 1.304
Nazione #
US - Stati Uniti d'America 865
IT - Italia 105
SG - Singapore 76
IN - India 49
SE - Svezia 47
CN - Cina 41
DE - Germania 23
CA - Canada 11
FI - Finlandia 11
IE - Irlanda 10
BG - Bulgaria 8
ID - Indonesia 8
FR - Francia 7
CZ - Repubblica Ceca 6
RO - Romania 6
AT - Austria 4
GB - Regno Unito 4
MY - Malesia 3
JP - Giappone 2
AR - Argentina 1
AU - Australia 1
BZ - Belize 1
DK - Danimarca 1
EU - Europa 1
KH - Cambogia 1
KR - Corea 1
LK - Sri Lanka 1
LV - Lettonia 1
MX - Messico 1
NL - Olanda 1
NZ - Nuova Zelanda 1
RU - Federazione Russa 1
SC - Seychelles 1
TR - Turchia 1
UA - Ucraina 1
VN - Vietnam 1
ZA - Sudafrica 1
Totale 1.304
Città #
Fairfield 156
Chandler 67
Singapore 65
Ashburn 60
Woodbridge 55
Cambridge 50
Rome 50
Houston 49
Dearborn 45
Seattle 41
Ann Arbor 30
Wilmington 24
Santa Clara 23
Fremont 22
Princeton 22
Beijing 18
Milan 13
Plano 13
San Paolo di Civitate 12
Boston 10
Dublin 10
Lawrence 10
New York 10
San Mateo 10
Jakarta 8
Millbury 8
Pune 8
Sofia 8
San Diego 7
Andover 6
Brno 6
Helsinki 6
Ottawa 6
San Jose 5
Toronto 5
Grafing 4
Paris 3
Phoenix 3
Vienna 3
Bremen 2
Bühl 2
Chiyoda-ku 2
Falkenstein 2
Jinan 2
Kunming 2
Livorno 2
Mannheim 2
Montello 2
Munich 2
Nanchang 2
Nanjing 2
Norwalk 2
Osimo 2
Prato 2
Ribera 2
San Michele al Tagliamento 2
Shanghai 2
Southend 2
Anzio 1
Ardea 1
Auckland 1
Baotou 1
Belize City 1
Changsha 1
Colombo 1
Columbus 1
Dallas 1
Des Moines 1
Dongying 1
Falls Church 1
Federal 1
Frosinone 1
Hebei 1
Hendon 1
Huizhou 1
Islington 1
Istanbul 1
Mexico City 1
Newark 1
Nuremberg 1
Phnom Penh 1
Redwood City 1
Riga 1
Sabaudia 1
Silverton 1
Taizhou 1
Thai Binh 1
Trumbull 1
University Center 1
Xi'an 1
Totale 1.021
Nome #
Persistent high plasma levels of sCD163 and sCD14 in adult patients with measles virus infection 114
Changes in inflammatory biomarkers in HCV-infected patients undergoing direct acting antiviral-containing regimens with or without interferon 107
Legionella pneumophila pneumonia during telaprevir-based triple therapy for HCV chronic hepatitis 103
Blood myeloid dendritic cells and slandc in antiretroviral therapy-suppressed hiv-infected patients 100
Therapeutic strategy for pan-drug resistant Klebsiella pneumoniae severe infections: short-course treatment with colistin increases the in vivo and in vitro activity of double carbapenem regimen 99
Myeloid and lymphoid activation markers in AIDS and non-AIDS presenters 91
Active HCV Replication but Not HCV or CMV Seropositive Status is associated with Incident and Prevalent Type 2 Diabetes in Persons living with HIV 87
Durability of different initial regimens in HIV-infected patients starting antiretroviral therapy with CD4+ counts <200 cells/mm3 and HIV-RNA >5 log10 copies/mL 79
Active HCV infection is associated with increased circulating levels of interferon-gamma (IFN-γ)-inducible protein-10 (IP-10), soluble CD163 and inflammatory monocytes regardless of liver fibrosis and HIV coinfection 76
Is physician assessment of alcohol consumption useful in predicting risk of severe liver disease among people with HIV and HIV/HCV co-infection? 69
Clearance of human papillomavirus related anal condylomas after oral and endorectal multistrain probiotic supplementation in an HIV positive male: a case report. 67
First-line antiretroviral therapy with efavirenz plus tenofovir disiproxil fumarate/emtricitabine or rilpivirine plus tenofovir disiproxil fumarate/emtricitabine: a durability comparison 67
null 53
null 49
null 35
Evaluation of blood plasmacytoid dendritic cells and inflammatory monocytes during firstwave HCV protease inhibitor therapy 29
null 27
Baseline myeloid and lymphoid activation markers can predict time to viral load reduction under 50 copies/mL and CD4 recovery, respectively, after highly active antiretroviral therapy initiation 21
Impact of IFN-Free and IFN-Based Treatment on Blood Myeloid Dendritic Cell, Monocyte, Slan-DC, and Activated T Lymphocyte Dynamics during HCV Infection 21
Impact of ifn-free and ifn-based treatment on blood myeloid dendritic cell, monocyte, slan-dc, and activated t lymphocyte dynamics during hcv infection 18
Response to first-line ritonavir-boosted protease inhibitors (PI/r)-based regimens in HIV positive patients presenting to care with low CD4 counts: Data from the Icona Foundation Cohort 18
Longitudinal assessment of multiple immunological and inflammatory parameters during successful DAA therapy in HCV monoinfected and HIV/HCV coinfected subjects 15
Peripheral Blood Inflammatory Monocytes are Increased in Hcv Infected Subjects in Comparison with Art Treated Hcv/hiv Coinfected with Similar Fibrosis Stage 13
Steroid use in measles: A retrospective cohort study during the 2017 outbreak in tertiary referral center, Rome and Latina, Italy 7
null 4
null 3
Totale 1.372
Categoria #
all - tutte 4.208
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 4.208


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020242 0 0 0 0 0 54 60 32 41 27 15 13
2020/2021100 13 15 6 1 4 16 1 2 24 14 4 0
2021/2022203 5 7 19 16 28 5 1 31 13 10 37 31
2022/2023228 46 43 21 22 18 23 7 15 17 2 7 7
2023/2024143 9 19 3 11 11 33 1 6 3 18 11 18
2024/2025148 7 48 16 20 25 32 0 0 0 0 0 0
Totale 1.372